Search
Miramar, FL Paid Clinical Trials
A listing of 19 clinical trials in Miramar, FL actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 19 of 19
There are currently 19 clinical trials in Miramar, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including FXM Research - Miramar, Comprehensive Phase One and South Broward Research LLC. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
Featured Trial
Irritability Associated with Autism (Children and Adolescents) Study
Recruiting
Join a clinical trial today and take a step toward finding a better solution for you. Earn money for your time and no-cost medical treatment is provided.
A Study of MK-0616 (Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids
Recruiting
The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The primary hypothesis is that MK-0616 is superior to placebo on mean percent change from baseline in low-density lipoprotein cholesterol (LDL-C) at Week 24.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: South Broward Research ( Site 0051), Miramar, Florida
Conditions: Hypercholesterolemia, Familial Hypercholesterolemia
MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
Recruiting
This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of MK-0616, an oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in participants with high cardiovascular risk. The primary objective is to evaluate the efficacy of MK-0616 compared with placebo in increasing the time to the first occurrence of major adverse cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb ischemi... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: Eminat ( Site 0082), Miramar, Florida
Conditions: Arteriosclerosis, Hypercholesterolaemia
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
Recruiting
This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.
Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). This is known as the study medicine. Which treatment participants get is decided by chance. Participants chance of getting ziltivekimab or placebo is the same.
Z... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/01/2024
Locations: Office of Kenneth Blaze DO, Miramar, Florida
Conditions: Cardiovascular Risk, Chronic Kidney Disease, Inflammation
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Recruiting
This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Site # 05, Miramar, Florida
Conditions: Moderate to Severe Plaque Psoriasis
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Recruiting
This is a Phase 2b randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of three active dose regimens of MORF-057 in adult patients with moderately to severely active Ulcerative Colitis (UC).
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
02/23/2024
Locations: Clinical Study Site, Miramar, Florida
Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative
Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
Recruiting
The purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use application for temporary relief of diabetic neuropathy foot pain in individuals diagnosed with diabetic neuropathy by a suitably qualified and licensed health professional.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/08/2024
Locations: FRANCO & CO Podiatric Medicine & Surgery, Miramar, Florida
Conditions: Neuropathy, Diabetic, Neuropathy;Peripheral, Neuropathy, Painful
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Recruiting
The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: Innovia Research Center, INC, Miramar, Florida
Conditions: Severe Hypertriglyceridemia
13 - 19 of 19